Application of Novel Methods for Non-Small Cell Lung Cancer (Nsclc) Biomarker Discovery

1. Aoki T, Tsuchida M, Watanabe T, Hashimoto T, Koike T, Hirono T, Hayashi J. Surgical strategy for clinical stage I non-small cell lung cancer in octogenarians. // Eur J Cardiothorac Surg, 2003; 23(4):446-450.10.1016/S1010-7940(03)00014-9Search in Google Scholar

2. Balgkouranidou I, Liloglou T, Lianidou ES. Lung cancer epigenetics: emerging biomarkers. // Biomark Med, 2013; 7(1):49-58.10.2217/bmm.12.111Search in Google Scholar

3. Chida M, Minowa M, Karube Y, Eba S, Okada Y, Miyoshi S, Kondo T. Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymphnode dissection. // Interact CardioVasc Thorac Surg, 2009; 8(1):89-92.10.1510/icvts.2008.193383Search in Google Scholar

4. Das-Neves-Pereira JC, Bagan P, Coimbra-Israel AP, Grimaillof-Junior A, Cesar-Lopez G, Milanez-de- Campos JR, Riquet MR, Biscegli-Jatene F. Fasttrack rehabilitation for lung cancer lobectomy: a five-year experience. // Eur J Cardiothorac Surg, 2009; 36(2):383-392.10.1016/j.ejcts.2009.02.020Search in Google Scholar

5. Gao WM, Kuick R, Orchekowski RP, et al. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. // BMC Cancer, 2005; 5:110.10.1186/1471-2407-5-110Search in Google Scholar

6. Giovannetti R, Alifano M, Stefani A, Legras A, Grigoroiu M, Collet JY, Magdelenat P, Regnard JF. Surgical treatment of bronchiectasis: early and long-term results. // Interact CardioVasc Thorac Surg, 2008; 7(4):609-612.10.1510/icvts.2007.163972Search in Google Scholar

7. Ferguson MK, Celauro AD, Vigneswaran WT. Validation of a modified scoring system for cardiovascular risk associated with major lung resection. // Eur J Cardiothorac Surg, 2012; 41(3):598-602.10.1093/ejcts/ezr081Search in Google Scholar

8. Ferguson MK and Durkin AE. A comparison of three scoring systems for predicting complications after major lung resection. // Eur J Cardiothorac Surg, 2003; 23(1):35-42.10.1016/S1010-7940(02)00675-9Search in Google Scholar

9. Khan N, Cromer CJ, Campa M, et al. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. // Cancer, 2004; 101:379-384.10.1002/cncr.2037715241837Search in Google Scholar

10. Kojima F, Yamamoto K, Matsuoka K, Ueda M, Hamada H, Imanishi N, Miyamoto Y. Factors affecting survival after lobectomy with pulmonary artery resection for primary lung cancer. // Eur J Cardiothorac Surg, 2011; 40(1):13-20.10.1016/j.ejcts.2011.02.02621435895Search in Google Scholar

11. Kouritas VK, Zissis C and Bellenis I. Variation of the postoperative fluid drainage according to the type of lobectomy. // Interact CardioVasc Thorac Surg, 2013; 16(4):437-440.10.1093/icvts/ivs529Search in Google Scholar

12. López E, Cho WC. Phosphoproteomics and lung cancer research. // Int J Mol Sci, 2012; 13(10):12287-314.10.3390/ijms131012287Search in Google Scholar

13. Matsuoka H, Okada M, Sakamoto T, Tsubota N. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age. // Eur J Cardiothorac Surg, 2005; 28(3):380-383.10.1016/j.ejcts.2005.06.010Search in Google Scholar

14. Paesmans M. Prognostic and predictive factors for lung cancer. Review. // Eur Respir J Breathe, 2012; 9:113 - 122.Search in Google Scholar

15. Pastor MD, Nogal A, Molina-Pinelo S, Meléndez R, Romero-Romero B, Mediano MD, López-Campos JL, García-Carbonero R, Sanchez-Gastaldo A, Carnero A, Paz-Ares L. Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage. // Int J Mol Sci, 2013; 14(2):3440-55.10.3390/ijms14023440Search in Google Scholar

16. Patz EF Jr, Campa MJ, Gottlin EB, et al. Panel of serum biomarkers for the diagnosis of lung cancer. // J Clin Oncol, 2007; 25:5578-5583.10.1200/JCO.2007.13.5392Search in Google Scholar

17. Sakuragi T, Sakao Y, Furukawa K, Rikitake K, Ohtsubo S, Okazaki Y, Natsuaki M, Itoh T. Successful management of acute pulmonary embolism after surgery for lung cancer. // Eur J Cardiothorac Surg, 2003; 24(4):580-587.10.1016/S1010-7940(03)00392-0Search in Google Scholar

18. Szczesny TJ, Slotwinski R, Stankiewicz A, Szczygiel B, Zaleska M, Kopacz M. Interleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgery. // Eur J Cardiothorac Surg, 2007; 31(4):719-724.10.1016/j.ejcts.2007.01.02717317198Search in Google Scholar

19. Taenzer A, Alix-Panabières C, Wikman H, Pantel K. Circulating tumor-d erived biomarkers in lung cancer. // J Thorac Dis, 2012; 4(5):448-9.Search in Google Scholar

20. Wang Y, Hu Y, Wang D, Yu K, Wang L, Zou Y, Zhao C, Zhang X, Wang P, Ying K. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. // Cancer Biomark, 2012; 11(4):129-37. 10.3233/CBM-2012-0027023144150Search in Google Scholar